Structural Basis for Achieving GSK-3β Inhibition with High Potency, Selectivity, and Brain Exposure for Positron Emission Tomography Imaging and Drug Discovery.


Journal

Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531

Informations de publication

Date de publication:
14 11 2019
Historique:
pubmed: 20 9 2019
medline: 17 6 2020
entrez: 20 9 2019
Statut: ppublish

Résumé

Using structure-guided design, several cell based assays, and microdosed positron emission tomography (PET) imaging, we identified a series of highly potent, selective, and brain-penetrant oxazole-4-carboxamide-based inhibitors of glycogen synthase kinase-3 (GSK-3). An isotopologue of our first-generation lead, [

Identifiants

pubmed: 31535859
doi: 10.1021/acs.jmedchem.9b01030
pmc: PMC6883410
mid: NIHMS1059284
doi:

Substances chimiques

Oxazoles 0
PF-04802367 0
Protein Kinase Inhibitors 0
Triazoles 0
Glycogen Synthase Kinase 3 beta EC 2.7.11.1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

9600-9617

Subventions

Organisme : NIA NIH HHS
ID : R01 AG054473
Pays : United States

Références

Biochem Biophys Res Commun. 2003 Dec 26;312(4):922-9
pubmed: 14651959
EMBO J. 2001 Jan 15;20(1-2):27-39
pubmed: 11226152
Virchows Arch. 2002 Oct;441(4):358-67
pubmed: 12404061
Cell. 2005 Jan 14;120(1):137-49
pubmed: 15652488
Sci Transl Med. 2018 Mar 7;10(431):
pubmed: 29515000
Neuroscience. 2007 Mar 2;145(1):209-24
pubmed: 17223274
Nat Neurosci. 2011 Jun;14(6):750-6
pubmed: 21532579
Molecules. 2015 Dec 09;20(12):22000-27
pubmed: 26690113
J Chem Inf Model. 2012 Jan 23;52(1):210-24
pubmed: 22133077
Nature. 2000 Jul 6;406(6791):86-90
pubmed: 10894547
Nat Rev Mol Cell Biol. 2001 Oct;2(10):769-76
pubmed: 11584304
Curr Top Dev Biol. 2017;123:277-302
pubmed: 28236969
Nat Rev Drug Discov. 2018 May;17(5):353-377
pubmed: 29545548
J Chem Inf Model. 2009 Nov;49(11):2564-71
pubmed: 19928836
Int J Alzheimers Dis. 2011;2011:189246
pubmed: 21629738
EMBO J. 1990 Aug;9(8):2431-8
pubmed: 2164470
Nat Neurosci. 2015 Dec;18(12):1819-31
pubmed: 26523646
Nat Rev Drug Discov. 2004 Jun;3(6):479-87
pubmed: 15173837
Nat Rev Neurosci. 2010 Aug;11(8):539-51
pubmed: 20648061
J Neurochem. 2008 Mar;104(6):1433-9
pubmed: 18088381
J Biomol Screen. 2012 Oct;17(9):1252-63
pubmed: 22923789
Neurosci Lett. 1992 Dec 14;148(1-2):202-6
pubmed: 1284442
Nat Rev Drug Discov. 2017 Dec;16(12):863-883
pubmed: 28983098
Nature. 2003 May 22;423(6938):435-9
pubmed: 12761548
Nat Rev Neurosci. 2007 Sep;8(9):663-72
pubmed: 17684513
J Med Chem. 2016 Feb 11;59(3):1041-51
pubmed: 26751161
J Neurosci. 2012 Jan 25;32(4):1360-5
pubmed: 22279220
J Med Chem. 2013 Jun 13;56(11):4568-79
pubmed: 23651455
Int J Alzheimers Dis. 2011;2011:505607
pubmed: 21629754
Nat Biotechnol. 2011 Oct 30;29(11):1046-51
pubmed: 22037378
Neurosci Lett. 1992 Nov 23;147(1):58-62
pubmed: 1336152
Nat Neurosci. 2009 Nov;12(11):1390-7
pubmed: 19801986
Angew Chem Int Ed Engl. 2016 Aug 8;55(33):9601-5
pubmed: 27355874
Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):2173-8
pubmed: 14769913
J Neuropathol Exp Neurol. 1997 Jan;56(1):70-8
pubmed: 8990130
Curr Protoc Hum Genet. 2017 Jan 11;92:21.8.1-21.8.21
pubmed: 28075486
Dev Cell. 2007 Jun;12(6):957-71
pubmed: 17543867
Elife. 2014 Mar 18;3:e01998
pubmed: 24642411
Neuropathol Appl Neurobiol. 2007 Feb;33(1):43-55
pubmed: 17239007
Nat Commun. 2015 Oct 26;6:8372
pubmed: 26496802
Nat Neurosci. 2018 Jan;21(1):130-138
pubmed: 29203896
Proc Natl Acad Sci U S A. 2005 May 10;102(19):6990-5
pubmed: 15867159
J Biol Chem. 1995 Jan 20;270(3):987-90
pubmed: 7836418
ACS Chem Biol. 2016 Jul 15;11(7):1952-63
pubmed: 27128528
Nature. 1995 Dec 21-28;378(6559):785-9
pubmed: 8524413
Front Mol Neurosci. 2011 Aug 26;4:17
pubmed: 21904524
J Chem Inf Model. 2008 Apr;48(4):902-9
pubmed: 18341269
Nat Biotechnol. 2011 Oct 30;29(11):1039-45
pubmed: 22037377
Theranostics. 2016 Feb 17;6(4):571-93
pubmed: 26941849

Auteurs

Vadim Bernard-Gauthier (V)

Azrieli Centre for Neuro-Radiochemistry, Research Imaging Centre , Centre for Addiction and Mental Health , Toronto , Ontario M5T 1R8 , Canada.
Department of Psychiatry/Institute of Medical Science , University of Toronto , Toronto , Ontario M5T 1R8 , Canada.
Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital and Department of Radiology , Harvard Medical School , Boston , Massachusetts 02114 , United States.

Andrew V Mossine (AV)

Division of Nuclear Medicine, Department of Radiology , The University of Michigan Medical School , Ann Arbor , Michigan 48109 , United States.

Ashley Knight (A)

Azrieli Centre for Neuro-Radiochemistry, Research Imaging Centre , Centre for Addiction and Mental Health , Toronto , Ontario M5T 1R8 , Canada.
Department of Psychiatry/Institute of Medical Science , University of Toronto , Toronto , Ontario M5T 1R8 , Canada.
Eisai AiM Institute , Boston , Massachusetts 01810 , United States.

Debasis Patnaik (D)

Chemical Neurobiology Laboratory, Massachusetts General Hospital, Center for Genomic Medicine, Departments of Neurology & Psychiatry , Harvard Medical School , Boston , Massachusetts 02114 , United States.

Wen-Ning Zhao (WN)

Chemical Neurobiology Laboratory, Massachusetts General Hospital, Center for Genomic Medicine, Departments of Neurology & Psychiatry , Harvard Medical School , Boston , Massachusetts 02114 , United States.

Chialin Cheng (C)

Chemical Neurobiology Laboratory, Massachusetts General Hospital, Center for Genomic Medicine, Departments of Neurology & Psychiatry , Harvard Medical School , Boston , Massachusetts 02114 , United States.

Hema S Krishnan (HS)

Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital and Department of Radiology , Harvard Medical School , Boston , Massachusetts 02114 , United States.

Lucius L Xuan (LL)

Chemical Neurobiology Laboratory, Massachusetts General Hospital, Center for Genomic Medicine, Departments of Neurology & Psychiatry , Harvard Medical School , Boston , Massachusetts 02114 , United States.

Peter S Chindavong (PS)

Chemical Neurobiology Laboratory, Massachusetts General Hospital, Center for Genomic Medicine, Departments of Neurology & Psychiatry , Harvard Medical School , Boston , Massachusetts 02114 , United States.

Surya A Reis (SA)

Chemical Neurobiology Laboratory, Massachusetts General Hospital, Center for Genomic Medicine, Departments of Neurology & Psychiatry , Harvard Medical School , Boston , Massachusetts 02114 , United States.

Jinshan Michael Chen (JM)

Pfizer Worldwide Research and Development , Groton Laboratories , Eastern Point Road , Groton , Connecticut 06340 , United States.

Xia Shao (X)

Division of Nuclear Medicine, Department of Radiology , The University of Michigan Medical School , Ann Arbor , Michigan 48109 , United States.

Jenelle Stauff (J)

Division of Nuclear Medicine, Department of Radiology , The University of Michigan Medical School , Ann Arbor , Michigan 48109 , United States.

Janna Arteaga (J)

Division of Nuclear Medicine, Department of Radiology , The University of Michigan Medical School , Ann Arbor , Michigan 48109 , United States.

Phillip Sherman (P)

Division of Nuclear Medicine, Department of Radiology , The University of Michigan Medical School , Ann Arbor , Michigan 48109 , United States.

Nicolas Salem (N)

Biogen, Research and Early Development Imaging , Cambridge , Massachusetts 02142 , United States.

David Bonsall (D)

Invicro , London W12 0NN , U.K.

Brenda Amaral (B)

Biogen, Research and Early Development Imaging , Cambridge , Massachusetts 02142 , United States.

Cassis Varlow (C)

Azrieli Centre for Neuro-Radiochemistry, Research Imaging Centre , Centre for Addiction and Mental Health , Toronto , Ontario M5T 1R8 , Canada.

Lisa Wells (L)

Invicro , London W12 0NN , U.K.

Laurent Martarello (L)

Biogen, Research and Early Development Imaging , Cambridge , Massachusetts 02142 , United States.

Shil Patel (S)

Eisai AiM Institute , Boston , Massachusetts 01810 , United States.

Steven H Liang (SH)

Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital and Department of Radiology , Harvard Medical School , Boston , Massachusetts 02114 , United States.

Ravi G Kurumbail (RG)

Pfizer Worldwide Research and Development , Groton Laboratories , Eastern Point Road , Groton , Connecticut 06340 , United States.

Stephen J Haggarty (SJ)

Chemical Neurobiology Laboratory, Massachusetts General Hospital, Center for Genomic Medicine, Departments of Neurology & Psychiatry , Harvard Medical School , Boston , Massachusetts 02114 , United States.

Peter J H Scott (PJH)

Division of Nuclear Medicine, Department of Radiology , The University of Michigan Medical School , Ann Arbor , Michigan 48109 , United States.
The Interdepartmental Program in Medicinal Chemistry , University of Michigan , Ann Arbor , Michigan 48109 , United States.

Neil Vasdev (N)

Azrieli Centre for Neuro-Radiochemistry, Research Imaging Centre , Centre for Addiction and Mental Health , Toronto , Ontario M5T 1R8 , Canada.
Department of Psychiatry/Institute of Medical Science , University of Toronto , Toronto , Ontario M5T 1R8 , Canada.
Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital and Department of Radiology , Harvard Medical School , Boston , Massachusetts 02114 , United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH